Resources

Publications

02/14/2025
- Oncology
Racial Diversity and Co-Mutational Analysis of Biologically Relevant Alterations in EGFR Mutant Lung Cancers
Clinical Lung Cancer
02/10/2025
- Oncology
Impact of PSA Nadir on Long-Term Survival in Metastatic Hormone-Sensitive Prostate Cancer: Final 10-Year Analysis of the ECOG-ACRIN E3805 CHAARTED Trial
ASCO GU 2025
02/10/2025
- Oncology
Molecular Subtypes, NECTIN4/HER2 Expression, and Clinical Outcomes in Patients (Pts) With Advanced Urothelial Carcinoma (aUC) or Muscle Invasive Bladder Cancer (MIBC): Exploratory Analyses From JAVELIN Bladder 100 and the Tempus Database
ASCO GU 2025
02/05/2025
- Oncology
Acquired RUFY1-RET Rearrangement as a Mechanism of Resistance to Lorlatinib in a Patient With CD74-ROS1 Rearranged Non-Small Cell Lung Cancer: A Case Report
Oncotarget
01/27/2025
- Oncology
Correlation of Mesothelin (MSLN) Expression Measured by RNA Sequencing (RNASeq) and Immunohistochemistry (IHC) in MSLN-Expressing Tumors
ASCO GI 2025
01/22/2025
- Oncology
Real-World Clinical Multi-Omics Analyses Reveal Bifurcation of ER-Independent and ER-Dependent Drug Resistance to CDK4/6 Inhibitors
Nature Communications
01/22/2025
- Oncology
Molecular Differences in Pancreatic Ductal Adenocarcinomas from Black versus White Patients
Cancer Research Communications
01/21/2025
- Oncology
Characterization of the Tumor Immune Microenvironment (TIME) and Somatic Landscape in Gastrointestinal (GI) Malignancies With MTAP Deletions (Del)
ASCO GI 2025
01/21/2025
- Oncology
Concordance Between Human Epidermal Growth Factor Receptor 2 (HER2) Status by Immunohistochemistry (IHC) and Next-Generation Sequencing (NGS) in Tissue and Blood Samples From Gastric and Gastroesophageal Junction Cancers (GC/GEJC)
ASCO GI 2025
01/21/2025
- Oncology
Association Between Ex Vivo Pharmacotyping of Patient-Derived Tumor Organoids and Personalized Therapeutic Options for Patients With Biliary Tract Cancer
ASCO GI 2025

10 11 12